Modulation of glucocorticoid receptor gene expression by antidepressant drugs

Pharmacopsychiatry

Volumn 29, Issue 1, 1996, Pages 12-22

  Barden, N ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; IMIPRAMINE; MESSENGER RNA; NEUROTRANSMITTER;

ANIMAL EXPERIMENT; ARTICLE; DEPRESSION; GENE EXPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MONOAMINERGIC SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0030029963     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979536     Document Type: Article

References (92)

1. Amsterdam, J. D., D. L. Marinelli, P. Arger, A. Winokur: Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: a pilot study. Psychiatry Res. 21 (1987) 189-197
2. Arriza, J. L., C. Weinberger, G. Cerelli, T. M. Glaser, B. L. Handelin, D. E. Housman, R. E. Evans: Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237 (1987) 268-275
3. Barden, N.: Corticosteroid receptor modulation in transgenic animals. Ann. N. Y. Acad. Sci. 746 (1994) 89-100
4. Beaulieu, S., N. Barden: Antidepressant, serotoninergic and glucocorticoid modulation of GR mRNA in hypothalamic neurons. Neuroendocrinol. Lett. 9 (1987) 186
5. Benkelfat, C., M. A. Ellenbogen, P. Dean, R. M. Palmour, S.N. Young: Mood-lowering effect of tryptophan depletion - enhanced susceptibility in young men at genetic risk for major affective disorders. Arch. Gen. Psychiatry 51 (1994) 687-697
6. Biegon, A., T.C. Rainbow, B. McEwen: Corticosterone modulation of neurotransmitter receptors in rat hippocampus: a quantitative autoradiographic study. Brain Res. 332 (1985) 309-314
7. Boyle M., G. Yamamoto, M. Chen, J. Rivier, W. Vale: Interleukin 1 prevents loss of corticotropic responsiveness to β-adrenergic stimulation in vitro. Proc. Natl. Acad. Sci. U.S.A. 85 (1988)
8. Bradbury, M. J., S. F. Akana, C. S. Cascio, N. Levin, L. Jacobson, M. F. Dallman: Regulation of basal ACTH secretion by corticosterone is mediated by both type I (MR) and type II (GR) receptors in rat brain. J. Steroid Biochem. Mol. Biol. 40 (1991) 133-142
9. Bradford, M. M.: A rapid method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
10. Brady, L. S., H. J. Whitfield, Jr., R. J. Fox, P. W. Gold, M. Herkenham: Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. J. Clin. Invest. 87 (1991) 831-837
11. Calogero, A. E., W. T. Galluchi, P. W. Gold, G. P. Chrousos: Multiple feedback regulation loops upon rat hypothalamic corticotropin-releasing hormone secretion: potential clinical implications. J. Clin. Invest. 82 (1988) 767-774
12. Carnes, M., C. M. Barksdale, N. H. Kalin, M. S. Brownfield, S. J. Lent: Effects of dexamethasone on central and peripheral ACTH systems in the rat. Neuroendocrinol. 45 (1987) 160-164
13. Carroll, B. J., G. C. Curtis, J. Mendels: Neuroendocrine regulation in depression I. Limbic system-adrenocortical dysfunction. Arch. Gen. Psychiatry 33 (1976) 1039-1050
14. Chalmers, D. T., J. F. Lopez, D. M. Vazquez, H. Akil, S. J. Watson: Regulation of hippocampal 5-HT1A receptor gene expression by dexamethasone. Neuropsychopharmacology 10 (1994) 215-222
15. Chirgwin, J., A. Pryzbala, R. MacDonald, W. Rutter: Isolation of biologically active ribonucleic acid from sources enriched in ribo-nuclease. Biochemistry 8 (1979) 5294-5299
16. Cintra, A., M. Zoli, L. Rosen, L. F. Agnati, S. Okret, A. C. Wikstrom, J. A. Gustafsson, K. Fuxe: Mapping and computer assisted morphometry and microdensitometry of glucocorticoid receptor immunoreactive neurons and glial cells in the rat central nervous system. Neuroscience 62 (1994) 843-897
17. Dallman, M. F., N. Levin, C. S. Cascio, S. F. Akana, L. Jacobson, R. W. Kuhn: Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via type I corticosterone-preferring receptors. Endocrinology 124 (1989) 2844-2850
18. de Kloet, E. R., J. Van der Vies, D. De Wied: The site of the suppression of dexamethasone on pituitary-adrenal activity. Endocrinology 94 (1974) 61-73
19. de Kloet, E. R., G. L. Kovacs, G. Szabo, G. Telegdy, B. Bohus, D. H. G. Versteeg: Decreased serotonin turnover shortly after adrenalectomy: Selective normalization after corticosterone substitution. Brain Res. 239 (1982) 659-663
20. de Kloet, E. R.: Brain corticosteroid receptor balance and homeostatic control. Frontiers in Neuroendocrinology 12 (1991) 95-164
21. Dunn, A. J., C. W. Berridge: Physiological and behavioral responses to corticotropinreleasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15 (1990) 71-100
22. Farmer, S. R., K. M. Wan, A. Ben-Ze'ev, S. Penman: Regulation of actin mRNA levels and translation responds to changes in cell configuration. Mol. Cell Biol. 3 (1983) 182-189
23. Gold, P. W., G. Chrousos, C. Kellner, R. Post, A. Roy, P. Augerinos, H. Schulte, E. Oldfield, D. L. Loriaux: Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am. J. Psychiatry 141 (1984) 619-627
24. Gold, P. W., D. L. Loriaux, A. Roy: Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N. Engl. J. Med. 314 (1986) 1329-1335
25. Gorman, C.: High efficiency gene transfer into mammalian cells. In DNA cloning, Vol. 2 (Glover, D. M., ed.), IRL press, Oxford (1985) pp. 143-190
26. Gorman, C. M., L. F. Moffat, B. H. Howard: Recombinant genomes which express chloramphenicol-acetyl transferase in mammalian cells. Mol. Cell. Biol. 2 (1982) 1044-1051
27. Gotthardt, U., U. Schweiger, J. Fahrenberg, C. Lauer, F. Holsboer, I. Heuser: Cortisol ACTH and cardiovascular responses to a cognitive challenge paradigm in aging and depression. Am. J. Physiol. in press (1994)
28. Greden, J. F., R. Gardner, D. King, L. Grunhaus, B. J. Carroll, Z. Kronfol: Dexamethasone suppression test in antidepressant treatment of melancholia: the process of normalization and test-retest reproducibility. Arch. Gen. Psychiatry 40 (1983) 493-500
29. Guthrie, S., E. A. Lane, M. Linnoila: Monitoring of plasma drug concentrations in clinical psychopharmocology. In: Psychopharmacology: The third generation of progress (Meltzer, H.Y., ed.), Raven Press, New York (1987) pp. 1323-1338
30. Hanin, I., A. Frazer, J. Croughan, J. M. Davis, M. M. Katz, S. H. Koslow, J. W. Maas, P. E. Stokes: Depression: implications of clinical studies for basic research. Fed. Proc. 44 (1985) 85-90
31. Heuser, I., A. Yassouridis, F. Holsboer: The combined dexamethasone/CRH test: a refined test for psychiatric disorders. J. Psychiatr. Res. in press (1994a)
32. Heuser, I. J., U. Gotthardt, U. Schweiger, J. Schmider, C.-H. Lammers, M. Dettling, F. Holsboer: Age-associated changes of pituitary-adrenocortical hormone regulation in humans: Importance of gender. Neurobiol. Aging 15 (1994b) 227-231
33. Hill, M. R., R. D. Stith, R. E. McCallum: Human recombinant il-1 alters glucocorticoid receptor function in reuber hepatoma cells. J. Immunol. 141 (1988) 1522-1528
34. Holsboer, F., R. Liebl, E. Hofschuster: Repeated dexamethasone suppression test during depressive illness. Normalization of test result compared with clinical improvement. J. Affective Disord. 4 (1982) 93-101
35. Holsboer, F., U. von Bardeleben, A. Gerken, G. K. Stalla, O.-A. Müller: Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor (h-CRF) in depression. N. Engl. J. Med. 311 (1984) 1127
36. Holsboer, F., A. Gerken, G. K. Stalla, O. A. Müller: ACTH, cortisol and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery. Biol. Psychiatry 20 (1985) 276-286
37. Holsboer, F., A. Gerken, U. von Bardeleben, W. Grimm, H. Beyer, O. A. Müller, G. K. Stalla: Human corticotropin-releasing hormone in depression. Biol. Psychiatry 21 (1986) 601-611
38. Holsboer, F., D. Spengler, I. Heuser: The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. In: Progress in Brain Research. Vol. 93 (Swaab, D. F., Hofman, M. A., Mirmiran, M., Ravid, R. and van Leeuwen, F. W., eds.), Elsevier, Amsterdam (1992) pp. 385-417
39. Holsboer-Trachsler, E., R. Stohler, M. Hatzinger: Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression. Psychiatry Res. 38 (1991) 163-171
40. Keller-Wood, M. E., M. F. Dallman: Corticosteroid inhibition of ACTH secretion. Endocr. Rev. 5 (1984) 1-24
41. Kitayama, I., A. M. Janson, A. Cintra, K. Fuxe, L. F. Agnati, S. O. Ogren, A. Harfstrand, P. Eneroth, J.-A. Gustafsson: Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. J. Neural Transm. 73 (1988) 191-203
42. Kramer, C. Y.: Extension of multiple range tests to group means with unequal number of replications. Biometrics 12 (1956) 307-310
43. 2 receptor-mediated wet-dog shakes behaviors. Psychopharmacology 108 (1992) 27-32
44. Kvetnansky, R., K. Fukuhara, K. Pacak, G. Cizza, D. S. Goldstein, I. J. Kopin: Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats. Endocrinology 133 (1993) 1411-1419
45. Linkowski, P., J. Mendlewicz, R. Leclercq, M. Brasseur, P. Hubain, J. Golstein, G. Copinschi, E. V. Cauter: The 24-hours profile of adrenocorticotropin and cortisol in major depressive illness. J. Clin. Endocrinol. Metab. 61 (1985) 429-438
46. Linkowski, P., M. Kerkhofs, A. Vanonderbergen, P. Hubain, G. Copinschi, M. Lhermitebaleriaux, R. Leclercq, M. Brasseur, J. Mendlewicz, E. Vancauter: The 24-hour profiles of cortisol, prolactin, and growth hormone secretion in mania. Arch. Gen. Psychiatry 51 (1994) 616-624
47. Lisansky, J., G. T. Peake, R. J. Strassman, C. Qualls, A. W. Meikle, C. Risch, G. A. Fava, M. Zownit-Brazis, P. Hochla, D. Britton: Augmented pituitary corticotropin response to a threshold dosage of human corticotropin-releasing hormone in depressives pretreated with metyrapone. Arch. Gen. Psychiatry 46 (1989) 641-649
48. Maes, M., H. Y. Meltzer, P. D'Hondt, P. Cosyns, P. Blockx: Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression. Psychoneuroendocrinol. 20 (1994) 149-167
49. Maes, M., H. Y. M. Meltzer: The serotonin hypothesis of major depression. In Psychopharmacology, the Fourth Generation of Progress (Bloom, F. E. and Kupfer, D. J., eds.), Raven Press, New York (1994)
50. 2 receptors in the dorsal hippocampus of male and female rats. Neuroendocrinol. 54 (1991) 454-461
51. Miesfeld, R., S. Okret, A.-C. Wikström, O. Wrange, J.-Å. Gustafsson, K. R. Yamamoto: Characterization of a steroid hormone receptor gene and mRNA in wild-type and mutant cells. Nature 312 (1984) 779-781
52. Montkowski, A., C. T. Wotjak, N. Barden, J. Ganster, I. Stec, M. Engelmann, J. M. H. M. Reul, R. Landgraf, F. Holsboer: Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J. Neuroendocrinol (1996) in press
53. Mortola, J. F., J. H. Liu, J. C. Gillin, D. D. Rasmussen, S. S. C. Yen: Pulsatile rhythms of adrenocorticotropin (ACTH) and xortisol in women with endogenous depression: evidence for increased ACTH pulse frequency. J. Clin. Endocrinol. Metab. 65 (1987) 962-968
54. Murphy, B. E. P.: Steroids and depression. J. Steroid Biochem. Mol. Biol. 38 (1991) 537-559
55. Murphy, B. E. P., D. Filipini, A. M. Ghadirian: Possible use of glucocorticoid receptor antagonists in the treatment of major depression: Preliminary results using RU 486. J. Psychiatr. Neurosci. 18 (1993) 209-213
56. Nemeroff, C. B., E. Widerlov, C. Bisette, H. Walléus, I. Karlson, K. Eklund, C. D. Kilts, P. T. Loosen, W. W. Vale: Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226 (1984) 1342-1343
57. Nemeroff, C. B., M. J. Owens, G. Bissette, A. C. Andorn, M. Stanley: Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch. Gen. Psychiatry 45 (1988) 577-579
58. Nemeroff, C. B., R. R. Krishnan, D. Reed, R. Leder, C. Beam, N. R. Dunnick: Adrenal gland enlargement in major depression: A computed tomographic study. Arch. Gen. Psychiatry 49 (1992) 384-387
59. Ogawa, T., M. Mikuni, Y. Kuroda, K. Muneoka, K. J. Mori, K. Takahashi: Effects of the altered serotonergic signalling by neonatal treatment with 5,7-dihydroxytryptamine, ritanserin or clomipramine on the adrenocortical stress response and the glucocorticoid receptor binding in the hippocampus in adult rats. J Neural. TransmGen. Sect. 96 (1994) 113-123
60. Owens, M. J., C. B. Nemeroff: Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43 (1991) 425-473
61. Payvar, F. P., D. De Franco, G. L. Firestone, B. Edgar, Ö. Wrange, S. Okret, J.-Å. Gustafsson, K. R. Yamamoto: Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell 35 (1983) 381-392
62. Peiffer, A., S. Veilleux, N. Barden: Antidepressant and other centrally-acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinol. 16 (1991) 505-515
63. Pepin, M.-C., S. Beaulieu, N. Barden: Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neural cultures. Mol. Brain Res. 6 (1989) 77-83
64. Pepin, M.-C., N. Barden: Decreased glucocorticoid receptor activity following glucocorticoid receptor antisense RNA gene fragment transfection. Mol. Cell. Biol. 11 (1991) 1647-1653
65. Pepin, M.-C., M. V. Govindan, N. Barden: Increased glucocorticoid receptor gene promoter activity following antidepressant treatment. Mol. Pharmacol. 41 (1992a) 1016-1022
66. Pepin, M.-C., F. Pothier, N. Barden: Impaired type II glucocorticoid receptor function in transgenic mice expressing antisense RNA. Nature 355 (1992b) 725-728
67. Pepin, M.-C., F. Pothier, N. Barden: Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol. Pharmacol. 42 (1992c) 991-995
68. Roadsheer, F. C. W. J. C. Hoogendijk, F. C. Stam, F. J. H. Tilders, D. F. Swaab: Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60 (1994) 436-444
69. Ratka, A., W. Sutanto, M. Bloemers, E. R. de Kloet: On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinol. 50 (1989) 117-123
70. Regestein, T. R., L. I. Rose G. H. Williams. Arch. Intern. Med. 130 (1982) 114-117
71. Reul, J. M. H. M., E. R. de Kloet: Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117 (1985) 2505-2512
72. Reul, J. M. H. M., I. Stec, M. Söder, F. Holsboer: Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 133 (1993) 312-320
73. Reul, J. M. H. M., M. S. Labeur, D. E. Grigoriadis, E. B. De Souza, F. Holsboer. Neuroendocrinol. in press
74. Richard, D., S. Chapdelaine, Y. Deshaies, M.-C. Pepin, N. Barden: Energy balance and lipid metabolism in transgenic mice bearing an antisense glucocorticoid receptor gene construct. Am. J. Physiol. 265 (1993) 146-150
75. Sachar, E. J., L. Hellman, H. P. Roffwarg, F. S. Halpern, D. K. Fukushima, T. F. Gallagher: Disrupted 24-h patterns of cortisol secretion in psychotic depression. Arch. Gen. Psychiatry 28 (1973) 19-24
76. Seckl, J. R., K. L. Dickson, G. Fink: Central 5,7-dihydroxytryptamine lesions decrease hippocampal glucocorticoid and mineralocorticoid receptor messenger ribonucleic acid expression. J. Neuroendocrinol. 2 (1990) 911-916
77. Seckl, J. R., G. Fink: Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinol. 55 (1992) 621-626
78. Shimoda, K., N. Yamada, K. Ohi, T. Tsujimoto, K. Takahashi, S. Takahashi: Chronic administration of tricyclic antidepressants suppress hypothalamo-pituitary-adrenocortical activity in male rats. Psychoneuroendocrinol. 13 (1988) 431-440
79. Silva, C. M., F. E. Powelloliver, C. M. Jewell, M. Sar, V. E. Allgood, J. A. Cidlowski: Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids. 59 (1994) 436-442
80. Singh, V. B., K. C. Corley, T. Phan, M. C. Boadle-Biber: Increases in the activity of tryptophan hydroxylase for rat cortex and midbrain in response to acute or repeated sound stress are blocked by adrenalectomy and restored by dexamethasone treatment. Brain Res. 516 (1990) 66-76
81. Southern, P. J., P. Berg: Transformation of mammalian cells to antiobiotic resistance with a bacterial gene under control of the SV40 early promoter. J. Mol. Appl. Genet. 1 (1982) 327-341
82. Stec, I., N. Barden, J. M. H. M. Reul, F. Holsboer: Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor. J. Psychiatr. Res. 28 (1994) 1-5
83. Suda, T., F. Tozawa, M. Yamada, T. Ushiyama, N. Tomori, T. Sumitomo, Y. Nakagami, D. Demura, K. Shizume: Insulin-induced hypoglycemia increases corticotropin-releasing factor messenger ribonucleic acid levels in rat hypothalamus. Endocrinology 123 (1988) 1371-1375
84. Szigethy, E., Y. Conwell, N. T. Forbes, C. Cox, E. D. Caine: Adrenal weight and morphology in victims of completed suicide. Biol. Psychiatry 36 (1994) 374-380
85. Torpy, D. J., J. E. Grice, G. I. Hockings, M. M. Walters, G. V. Crosbie, R. V. Jackson: Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evicence for synergy between vasopressin and corticotropin-releasing hormone in humans. J. Clin. Endocrinol. Metab. 79 (1994) 140-144
86. Van der Eb, A. J., F. L. Graham: Assay of transforming activity of tumor virus DNA. Methods Enzymol. 65 (1980) 826-839
87. von Bardeleben, U., G. K. Stalla, O. A. Müller, F. Holsboer: Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pre-treatment. Biol. Psychiatry 24 (1988) 782-786
88. von Bardeleben, U., F. Holsboer: Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression. J. Neuroendocrinol. 1 (1989) 485-488
89. Whalley, L. J., N. Borthwick, D. Copolov, H. Dick, J. E. Christie, G. Fink: Glucocorticoid receptors and depression. Br. Med. J. 292 (1986) 859-861
90. Young, A. H., L. M. MacDonald, H. St John, H. Dick, G. M. Goodwin: The effects of corticosterone on 5-HT receptor function in rodents. Neuropharmacology 31 (1992) 433-438
91. Young, E. A., R. F. Haskett, V. Murphy-Weinberg, S. J. Watson, H. Akil: Loss of glucocorticoid fast feedback in depression. Arch. Gen. Psychiatry 48 (1991) 693-699
92. Young, E. A., R. F. Haskett, L. Grunhaus, A. Pande, V. M. Weinberg, S. J. Watson, H. Akil: Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Arch. Gen. Psychiatry 51 (1994) 701-707